We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $397M
1-Year Est. Return 178.66%
This Fund
S&P 500
This Quarter Est. Return
+18.48%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$748M
AUM Growth
+$11.5M
Cap. Flow
-$43.9M
Cap. Flow %
-5.86%
Top 10 Hldgs %
21.83%
Holding
143
New
43
Increased
23
Reduced
42
Closed
33

Top Sells

Rank Stock Value
1
SITM icon
SiTime
SITM
+$17.1M
2
HALO icon
Halozyme
HALO
+$15.4M
3
LFUS icon
Littelfuse
LFUS
+$13.6M
4
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$12.7M
5
PLAY icon
Dave & Buster's
PLAY
+$12.2M

Sector Composition

Rank Sector Weight
1 Technology 26.34%
2 Healthcare 26.27%
3 Industrials 20.62%
4 Consumer Staples 10.04%
5 Consumer Discretionary 8.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BAH icon
26
Booz Allen Hamilton
BAH
$8.89B
$9.04M 1.21%
+97,890
New +$9.28M
EXLS icon
27
EXL Service
EXLS
$5.25B
$9M 1.2%
305,250
+174,725
+134% +$5.7M
SOVO
28
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
$8.8M 1.18%
618,185
-79,450
-11% -$1.16M
MANH icon
29
Manhattan Associates
MANH
$11.1B
$8.68M 1.16%
65,271
+19,780
+43% +$2.68M
CELH icon
30
Celsius Holdings
CELH
$6.08B
$8.6M 1.15%
+284,520
New +$8.91M
BOOT icon
31
Boot Barn
BOOT
$4.97B
$8.34M 1.11%
142,624
-63,697
-31% -$4.27M
CYTK icon
32
Cytokinetics
CYTK
$11B
$8.22M 1.1%
169,767
-163,505
-49% -$7.87M
TXRH icon
33
Texas Roadhouse
TXRH
$13.7B
$8.17M 1.09%
93,600
+51,075
+120% +$4.46M
EVH icon
34
Evolent Health
EVH
$404M
$7.95M 1.06%
221,380
-58,035
-21% -$2.04M
LSCC icon
35
Lattice Semiconductor
LSCC
$18.3B
$7.95M 1.06%
161,590
+52,380
+48% +$2.9M
CLH icon
36
Clean Harbors
CLH
$16.2B
$7.95M 1.06%
72,281
-33,170
-31% -$3.55M
ONT
37
Onterris Inc
ONT
$545M
$7.86M 1.05%
233,548
-3,710
-2% -$147K
DY icon
38
Dycom Industries
DY
$12B
$7.78M 1.04%
81,476
+18,040
+28% +$1.89M
FRPT icon
39
Freshpet
FRPT
$3.28B
$7.71M 1.03%
+153,925
New +$7.26M
LPLA icon
40
LPL Financial
LPLA
$28.3B
$7.61M 1.02%
34,830
INST
41
DELISTED
Instructure Holdings, Inc.
INST
$7.6M 1.02%
340,966
-38,540
-10% -$900K
AXNX
42
DELISTED
Axonics, Inc. Common Stock
AXNX
$7.56M 1.01%
107,272
-2,770
-3% -$191K
CROX icon
43
Crocs
CROX
$6.43B
$7.13M 0.95%
103,785
+21,380
+26% +$1.48M
RUN icon
44
Sunrun
RUN
$2.24B
$6.9M 0.92%
+250,225
New +$7.78M
AMN icon
45
AMN Healthcare
AMN
$1.19B
$6.86M 0.92%
64,712
+46,695
+259% +$5.12M
LNTH icon
46
Lantheus
LNTH
$6.6B
$6.58M 0.88%
93,620
+7,205
+8% +$546K
ENPH icon
47
Enphase Energy
ENPH
$5.24B
$6.43M 0.86%
23,172
-7,615
-25% -$2.05M
CSL icon
48
Carlisle Companies
CSL
$15.2B
$6.42M 0.86%
22,885
INSP icon
49
Inspire Medical Systems
INSP
$1.7B
$6.06M 0.81%
34,179
-30,825
-47% -$6.19M
AMRC icon
50
Ameresco
AMRC
$1.36B
$6.05M 0.81%
+90,955
New +$5.59M

Similar funds

Lisanti Capital Growth's Q3 2022 Portfolio in Review

As of Q3 2022, Lisanti Capital Growth held 143 positions worth $748M, up 1.6% from $736M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Lisanti Capital Growth withdrew a net $43.9M in Q3 2022, closing 33 positions and reducing 42 holdings. Its most notable exit was SiTime, an estimated $17.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Lisanti Capital Growth opened a new position in Wingstop worth $15.9M.

  • Lisanti Capital Growth's largest Q3 2022 buy was Wingstop: 126,975 shares worth $15.9M.
  • Lisanti Capital Growth added most to Advanced Drainage Systems in Q3 2022, an estimated $8.48M increase.
  • Lisanti Capital Growth's biggest Q3 2022 reduction was Intra-Cellular Therapies Inc., cutting an estimated $12.7M.
  • Lisanti Capital Growth fully exited SiTime in Q3 2022, selling an estimated $17.1M.
  • Lisanti Capital Growth's ten largest holdings make up 22% of its $748M portfolio in Q3 2022.
  • Lisanti Capital Growth opened 43 new positions and closed 33 in Q3 2022.
  • Lisanti Capital Growth's portfolio value rose 1.6% quarter-over-quarter to $748M.

Based on Lisanti Capital Growth's 13F filing for Q3 2022, filed 2 Nov 2022.